Leigh Syndrome (nuclear DNA mutation)
Clinical Genetic Test
Help
offered by
GTR Test Accession: Help GTR000227956.1
Last updated in GTR: 2013-05-22
Last annual review date for the lab: 2023-05-15 LinkOut
At a Glance
Diagnosis; Drug Response; Monitoring; ...
Leigh Syndrome (nuclear DNA mutation)
Genes (2): Help
SCO2 (22q13.33), SURF1 (9q34.2)
Molecular Genetics - Sequence analysis of the entire coding region: Bi-directional Sanger Sequence Analysis; ...
Not provided
Not provided
Not provided
Ordering Information
Offered by: Help
John Welsh Cardiovascular Diagnostic Laboratory
View lab's website
Specimen Source: Help
  • Amniocytes
  • Amniotic fluid
  • Bone marrow
  • Buccal swab
  • Cell culture
  • Cell-free DNA
  • Chorionic villi
  • Cord blood
  • Cystic hygroma fluid
  • Dried blood spot (DBS) card
  • Fetal blood
  • Fibroblasts
  • Fresh tissue
  • Frozen tissue
  • Isolated DNA
  • Paraffin block
  • Peripheral (whole) blood
  • Plasma
  • Product of conception (POC)
  • Saliva
  • Serum
  • Skin
  • Sputum
  • Urine
  • White blood cell prep
  • View specimen requirements
Who can order: Help
  • Licensed Physician
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
Test additional service: Help
Custom Prenatal Testing
Custom mutation-specific/Carrier testing
Test development: Help
Test developed by laboratory (no manufacturer test name)
Informed consent required: Help
Decline to answer
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 1
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 2
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 2
Method Category Help
Test method Help
Instrument *
Sequence analysis of the entire coding region
Bi-directional Sanger Sequence Analysis
Targeted variant analysis
Bi-directional Sanger Sequence Analysis
* Instrument: Not provided
Clinical Information
Test purpose: Help
Diagnosis; Drug Response; Monitoring; Mutation Confirmation; Pre-implantation genetic diagnosis; Pre-symptomatic; Risk Assessment; Screening
Recommended fields not provided:
Technical Information
Test Comments: Help
Sequence analysis of SCO2 and SURF1
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
99% detection of mutations in exons of SCO2 and SURF1
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
No
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Category: FDA exercises enforcement discretion
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.